Percutaneous Dilational Tracheostomy for Coronavirus Disease 2019 Patients Requiring Mechanical Ventilation*
OBJECTIVES:
To assess the impact of percutaneous dilational tracheostomy in coronavirus disease 2019 patients requiring mechanical ventilation and the risk for healthcare providers.
DESIGN:
Prospective cohort study; patients were enrolled between March 11, and April 29, 2020. The date of final follow-up was July 30, 2020. We used a propensity score matching approach to compare outcomes. Study outcomes were formulated before data collection and analysis.
SETTING:
Critical care units at two large metropolitan hospitals in New York City.
PATIENTS:
Five-hundred forty-one patients with confirmed severe coronavirus disease 2019 respiratory failure requiring mechanical ventilation.
INTERVENTIONS:
Bedside percutaneous dilational tracheostomy with modified visualization and ventilation.
MEASUREMENTS AND MAIN RESULTS:
Required time for discontinuation off mechanical ventilation, total length of hospitalization, and overall patient survival. Of the 541 patients, 394 patients were eligible for a tracheostomy. One-hundred sixteen were early percutaneous dilational tracheostomies with median time of 9 days after initiation of mechanical ventilation (interquartile range, 7–12 d), whereas 89 were late percutaneous dilational tracheostomies with a median time of 19 days after initiation of mechanical ventilation (interquartile range, 16–24 d). Compared with patients with no tracheostomy, patients with an early percutaneous dilational tracheostomy had...
Source: Critical Care Medicine - Category: Emergency Medicine Tags: Clinical Investigations Source Type: research
More News: Coronavirus | COVID-19 | Emergency Medicine | Hospitals | Respiratory Medicine | Study | Tracheostomy